These results provided a better understanding of the underlying mechanisms of PRRl1 and SKA2 in ESCC tumor development, and PRRl1 and SKA2 may be considered as potential targets for the diagnosis and/or treatment of ESCC. Here, SKA2 is linked to esophageal squamous cell carcinoma.